Abstract
Purpose: Poor prognosis TxN+M0 bladder cancer has limited evidence-based guidelines defining optimum management. We evaluated real-world outcomes and treatment approaches for patients at a tertiary oncology centre.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
